Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 22, Issue 2, 2006, Pages 121-124

  Lozsadi, D A ^a   Larner, A J ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Epilepsy; Seizures

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SEIZURE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTICONVULSANTS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SEIZURES;

EID: 33747392556     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093664     Document Type: Article

References (33)

1. Høgh P, Smith SJ, Scahill RI, Chan D, Harvey RJ, Fox NC, Rossor MN: Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment. Neurology 2002;58:298-301.
2. Kwan P, Brodie MJ: Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001;357:216-222.
3. Motamedi G, Meador K: Epilepsy and cognition. Epilepsy Behav 2003;4:S25-S38.
4. Aldenkamp AP, De Krom M, Reijs R: Newer antiepileptic drugs and cognitive issues. Epilepsia 2003;44(suppl):21-29.
5. Romanelli MF, Morris JC, Ashkin K, Coben LA: Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990;47:847-850.
6. Hauser WA, Morris ML, Heston LL, Anderson VE: Seizures and myoclonus in patients with Alzheimer's disease. Neurology 1986; 36:1226-1230.
7. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA: Dementia and adult-onset unprovoked seizures. Neurology 1996; 46:727-730.
8. Mendez MF, Lim GTH: Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 2003;20:791-803.
9. Neary D, Snowden JS, Bowen DM, et al: Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 1986;49:157-162.
10. Risse SC, Lampe TH, Bird TD, et al: Myoclonus, seizures and paratonia in Alzheimer's disease. Alzheimer Dis Assoc Disord 1990;4: 217-225.
11. Mendez MF, Catanzaro P, Doss RC, Arguello R, Frey WHJ: Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol 1994;7:230-233.
12. Seltzer B, Sherwin L: A comparison of clinical features in early- and late-onset primary degenerative dementia. Arch Neurol 1983; 40:143-146.
13. Chandra V, Bharucha NE, Schoenberg BS: Conditions associated with Alzheimer's disease at death: case-control studies. Neurology 1986;36:209-211.
14. McAreavey MJ, Ballinger BR, Fenton GW: Epileptic seizures in elderly patients with dementia. Epilepsia 1992;33:657-660.
15. Volicer L, Smith S, Volicer BJ: Effect of seizures on progression of dementia of the Alzheimer type. Dementia 1995;6:258-263.
16. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer's disease. Neurology 1984;34: 939-944.
17. Larner AJ, Doran M: Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 2006;253:139-158.
18. Doran M, Larner AJ: Prominent behavioural and psychiatric symptoms in early-onset Alzheimer's disease in a sib pair with the presenilin-1 gene R269G mutation. Eur Arch Psychiatry Clin Neurosci 2004;254:187-189.
19. Moehlmann T, Winkler E, Xia X, et al: Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production. Proc Natl Acad Sci USA 2002;99:8025-8030.
20. Puri BK, Ho KW, Singh I: Age of seizure onset in adults with Down's syndrome. Int J Clin Pract 2001;55:442-444.
21. Scarmeas N, Honig L, Choi H, et al: Seizures in Alzheimer's disease: frequency and predictors (abstract P1090). Eur J Neurol 2005; 12(suppl 2):59.
22. Clark C, Heyman A, Earl N, Utley C, Haynes C: Myoclonus in Alzheimer's disease; in Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM (eds): Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. Chichester, Wiley, 1991, pp 35-40.
23. Commission of the Classification and Terminology of the International League against Epilepsy: Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
24. Commission on Classification and Terminology of the International League against Epilepsy: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
25. Larner AJ, du Plessis DG: Early-onset Alzheimer's disease with presenilin-1 M139V mutation: clinical, neuropsychological and neuropathological study. Eur J Neurol 2003; 10:319-323.
26. Joint Epilepsy Council: Epilepsy Prevalence, Incidence and Other Statistics. Leeds, Joint Epilepsy Council, 2005.
27. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS): Pathological correlates of late-onset dementia in a multicentre community-based population in England and Wales. Lancet 2001;357:169-175.
28. Leverenz JB, Agustin CM, Tsuang D, et al: Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol 2002;59:1099-1106.
29. Förstl H, Burns A, Levy R, Cairns N, Luthert P, Lantos P: Neurologic signs in Alzheimer's disease: results of a prospective clinical and neuropathologic study. Arch Neurol 1992; 49:1038-1042.
30. Pitkanen A, Sutula TP: Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 2002;1:173-181.
31. Larner AJ: Axonal sprouting and synaptogenesis in temporal lobe epilepsy: possible pathogenetic and therapeutic roles of neurite growth inhibitory factors. Seizure 1995;4: 249-258.
32. Larner AJ: The cortical neuritic dystrophy of Alzheimer's disease: nature, significance, and possible pathogenesis. Dementia 1995;6: 218-224.
33. Larner AJ: Neurite growth-inhibitory factors in Alzheimer's disease (abstract 1117). Neurobiol Aging 1998;19(suppl 4):S267.